Why Seek Labs’ amplification chemistry could matter beyond infectious disease testing
Molecular testing is powerful but lab-bound. Seek Labs’ patent raises a sharper question: can point-of-care diagnostics finally scale?
Can Karius and Mayo Clinic Laboratories push metagenomic infectious disease testing closer to routine hospital use?
Karius and Mayo Clinic Laboratories are expanding access to rapid metagenomic infection tests. Read what this could change for hospital diagnostics.
Why Bruker’s ESCMID 2026 microbiology expansion could matter for hospital labs and infection control
Bruker expanded its microbiology portfolio at ESCMID 2026. Read what the new MALDI and outbreak tools could mean for labs and infection control.
Is culture-free pneumonia testing finally viable as Pattern Bioscience nears regulatory submission
Pattern Bioscience advances rapid pneumonia diagnostics toward FDA clearance. Discover what this means for ICU care and antibiotic resistance.
How QIAGEN’s QIAstat-Dx Rise GI panel clearance could reshape multiplex pathogen testing in clinical labs
QIAGEN wins FDA clearance for GI panels on QIAstat-Dx Rise. Discover what this means for syndromic testing platforms and molecular diagnostics adoption.